Current and Potential Biologic Drugs for the Treatment of Chronic Urticaria

This article reviews biologic treatments that are currently applied for the treatment of severe chronic urticaria. Monoclonal anti –immunoglobulin E (omalizumab) is effective and safe in many patients, but accessibility and cost constitute barriers to its wider use. Questions on the optimal duration of the treatment and possible symptom recurrences after discontinuing the drug are still raised. A discussion is presented about several other biologics currently under investigation with potential to be incorporated in the near future in patients with severe chronic urticaria.
Source: Immunology and Allergy Clinics of North America - Category: Allergy & Immunology Authors: Source Type: research